Former FDA deputy commissioner Scott Gottlieb is the Trump administration’s top choice to head the agency, according to a Bloomberg report.
Gottlieb has held several senior positions at the FDA during the George W. Bush administration, and has regularly spoken on plans to lower prescription drug cost through modernizing the federal watchdog’s approval process, according to the report.